Pfizer and BioNTech laboratories claim to have discovered a vaccine that is 90% effective.

Currently in phase 3 of the clinical trial, this formula could quickly be produced on a large scale and distributed, if, however, no safety problem was detected.

Nine other vaccine candidates are still being tested.